Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Vycor Medical Files Q3 2026 Financial Results 8-K

Vycor Medical, Inc. filed a Form 8-K on November 16, 2026, furnishing a press release issued November 13, 2026, regarding financial results for the three and nine months ended September 30, 2026.

Manish Choudhary | 16 November 2026

Klygefa Approved in EU for Myasthenia Gravis Adults

AstraZeneca PLC filed a Form 6-K on 16 November 2026 disclosing that the European Commission has approved Klygefa (gefurulimab), developed by Alexion, AstraZeneca Rare Disease, as an add-on therapy for generalised myasthenia gravis in adults who are anti-acetylcholine receptor antibody positive.

Shwetambri Chauhan | 16 November 2026

Prudential plc Buys 2.5M Shares Nov 9-13, 2026

Prudential plc filed a Form 6-K with the SEC on 16 November 2026 disclosing the repurchase of 2,503,964 ordinary shares on the London Stock Exchange across five trading sessions from 9 to 13 November 2026.

Shwetambri Chauhan | 16 November 2026

T1 Energy Launches $100M At-the-Market Stock Offering

T1 Energy Inc. filed a Current Report on Form 8-K on November 16, 2026, disclosing the entry into an equity distribution agreement with Roth Capital Partners, LLC to sell up to $100,000,000 in common stock through an at-the-market offering.

Nitish Kishor | 16 November 2026

Cellyan Biotechnology Regains Nasdaq Minimum Bid Compliance

Cellyan Biotechnology Co., Ltd filed a Form 6-K on November 16, 2026, disclosing that it received a letter from Nasdaq on November 13, 2026, confirming the company had regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

Vinay Lochav | 16 November 2026

Harmony Gold Reports Fatal Incident at Mponeng Mine

Harmony Gold Mining Company Limited filed a Form 6-K with the SEC on November 16, 2026, disclosing a loss-of-life incident at its Mponeng mine in the West Rand of Gauteng, South Africa, that occurred on Saturday, November 14, 2026.

Shwetambri Chauhan | 16 November 2026

Epstein Buys 14,980 AgomAb Shares on November 13

Director David R. Epstein filed a Form 4 with the SEC on November 16, 2026, disclosing four open-market purchases of AgomAb Therapeutics NV common shares on November 13, 2026.

Manish Choudhary | 16 November 2026

Vista Energy Repurchases 30,000 Series A Shares at MXN 1,032.60

Vista Energy, S.A.B. de C.V. filed a Form 6-K with the U.S. Securities and Exchange Commission on November 16, 2026, disclosing a repurchase of 30,000 Series A shares on November 13, 2026.

Nitish Kishor | 16 November 2026

Rein Therapeutics Files Q3 2026 Report With $35.5M in New Investments

Rein Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 16, 2026, covering the period ended September 30, 2026, and reporting a significant build in investment holdings alongside a sharp increase in total assets.

Aditi Sarkar | 16 November 2026

Blackstone Digital Infrastructure Trust Q3 2026 Debut Filing

Blackstone Digital Infrastructure Trust Inc. filed its first Form 10-Q with the SEC on November 16, 2026, covering the quarterly period ended September 30, 2026, its inaugural operating quarter since incorporation in November 2025.

Shwetambri Chauhan | 16 November 2026
Support

Hi! How can we help you today?

Loading…